iHuman Inc (IH) FinancialsIHiHuman Inc

Evaluating the bottom line, iHuman Inc maintains a gross margin of 64.14%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -11.99%, while the net margin is -10.11%. These profitability ratios, combined with a Return on Equity (ROE) of 2.59%, provide a clear picture of how effectively IH converts its operational activities into shareholder value.

In the context of the broader market, IH competes directly with industry leaders such as CAST and OGCP. With a market capitalization of $59.30M, it holds a significant position in the sector. When comparing efficiency, IH's gross margin of 64.14% stands against CAST's 99.61% and OGCP's N/A. Such benchmarking helps identify whether iHuman Inc is trading at a premium or discount relative to its financial performance.

iHuman has shown a declining trend in revenue, with Q2 2026 revenue at 173.38 million CNY, down from 210.91 million CNY in Q2 2025. The gross margin has also decreased to 64.14% in Q2 2026 from 68.32% in Q1 2025, indicating pressure on profitability.